Best of Summer 2017
September 1, 2017
Vacation season? Perhaps. But summer hasn’t slowed the Institute for Patient Access’ steady stream of physician-led insight on policy issues that matter to patients and their health care providers.
As we head into September, here’s a look back at this summer’s highlights.
- Policymakers want to curb rising health care costs – but some approaches work better than others.
Video: Understanding Value-Based Contracting
Report: Cost-Motivated Treatment Changes & Non-Medical Switching
- Abuse-deterrent opioid formulations get the cold shoulder from the Institute for Clinical and Economic Review – despite their value in addressing abuse.
Infographic: Why Patients Need Access to Abuse-Deterrent Opioids
One-Pager: What’s Missing From ICER’s Assessment of Abuse-Deterrent Opioids
- International drug donation programs improve access and save lives. So how can we make them more widespread?
Policy paper: The Role of Drug Donations in Expanding Access to Medicines
- Promising research on preventive headache drugs raises hopes for those with debilitating conditions and few treatment options.
Blog: Research on Preventive Drugs Raises Hopes in the Migraine Community
Infographic: Who Are Migraines Hurting?
- Nearly one in five Americans with hepatitis C spends time behind bars each year. One doctor explains why policymakers should facilitate access to curative treatment – and how.
Policy paper: Testing and Treating Prisoners for Hepatitis C
- Co-pay coupons and assistance programs spark controversy. They also help patients access vital medicines.
Fast Facts: Co-Pay Coupons
- Obstacles mount for heart patients who need breakthrough PCSK9 inhibitors.
Blog: ICER Report Could Intensify Barriers for Heart Patients
Blog: One Step Forward, Two Steps Back for Heart Patients
Follow the blog this fall for more videos, policy papers and insights on patient access. Welcome back!Tags: Biologics, Cardiovascular, Cost Sharing, Hepatitis, Neurological, Prior Authorization, Step Therapy
Categorized in: Blog